Shuli F. Zhao
68 Changle Road
Nanjing, 210006, China
Nanjing, 210006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
A Stem Cell-Osteogenesis Axis in Malignant Breast Calcification: SQLE-Driven Reprogramming of Adipose-Derived Mesenchymal Stem Cells.
Journal: Stem cell reviews and reports
Published: February 17, 2026
Correction: DNAJC5 promotes cisplatin resistance in epithelial ovarian cancer by autophagy induced by the BiP/IRE1α/XBP1 endoplasmic reticulum stress pathway.
Journal: Scientific reports
Published: January 28, 2026
SSR4 sustains Tertiary Lymphoid Structures by Regulation Quality Control of N-linked Glycosylation During B-cell Differentiation Into Plasmacyte in Colorectal Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 07, 2025
Development of a 177Lu-labeled EphA2-targeting cyclic peptide combined with an HPK1 inhibitor for synergistic anti-tumor effects.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: June 24, 2025
Targeting the KRAS-p38-ATF4 axis enhances the therapeutic sensitivity of the peptide PDBAG1 in ovarian cancer via stress response modulation.
Journal: European journal of pharmacology
Published: May 06, 2025
NR4A3high mast cells promote ovarian cancer metastasis by reprogramming tumor-associated macrophages via JAK2/STAT6 signaling.
Journal: Translational oncology
Published: March 20, 2025
Aurka-Bhlhe41 axis prevents premature aging-like microglial dysfunction and promotes remyelination.
Journal: Nature communications
Published: March 13, 2025
DNAJC5 promotes cisplatin resistance in epithelial ovarian cancer by autophagy induced by the BiP/IRE1α/XBP1 endoplasmic reticulum stress pathway.
Journal: Scientific reports
Published: January 05, 2025
Identifying prognostic biomarkers and immune interactions in ovarian cancer associated with perfluorooctanoic acid exposure: Insights from comparative toxicogenomics and molecular docking studies.
Journal: Ecotoxicology and environmental safety
Published: November 14, 2024
CD81 Aggravates Ovarian Cancer Progression via p-Cresyl Sulfate-Mediated Mitophagy in Tim4+ Tumour-Associated Macrophages.
Journal: Journal of cellular and molecular medicine
Published: September 14, 2024
A new peptide inhibitor of C1QBP exhibits potent anti-tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair.
Journal: Clinical and translational medicine
Published: July 23, 2024
Last Updated: 09/26/2026